Specifically, ZDHHC9 has been demonstrated to enhance cGAS-mediated immune responses in the human breast cancer cell line MDA-MB-231 (15), whereas ZDHHC18 exerts a negative regulatory influence on cGAS-mediated immune responses in both human and murine macrophages (17). The gene discussed is ZDHHC9; the disease is breast cancer.